Viatris (VTRS) Raw Materials (2019 - 2026)
Viatris (VTRS) posted Raw Materials of $1.5 billion for Q2 2026, down 0.82% on a QoQ basis from $1.5 billion in Q1 2026, and down 5.79% year-over-year from $1.5 billion in Q2 2025.
Analysis
Viatris (VTRS) Raw Materials (2019 - 2026) Analysis & Trends
Viatris has reported Raw Materials for 8 years, with the latest figure at $1.5 billion in Q2 2026.
- On a quarterly basis, Raw Materials fell 5.79% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 5.79% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 5.68% from the prior year.
- Raw Materials was $1.5 billion for Q2 2026 at Viatris, down from $1.5 billion in the prior quarter.
- The five-year high for Raw Materials was $1.5 billion in Q2 2025, with the low at $417.5 million in Q2 2023.
- Average Raw Materials over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Raw Materials plunged 48.15% in 2023, then surged 198.51% in 2024.
- Over 5 years, Raw Materials stood at $571.5 million in 2022, then climbed by 28.03% to $731.7 million in 2023, then surged by 83.94% to $1.3 billion in 2024, then rose by 5.68% to $1.4 billion in 2025, then increased by 2.49% to $1.5 billion in 2026.
- The last three Raw Materials figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Bn |
| Mar 31, 2026 | 1.47 Bn |
| Dec 31, 2025 | 1.42 Bn |
| Sep 30, 2025 | 1.51 Bn |
| Jun 30, 2025 | 1.55 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 686.70 Mn |
| Dec 31, 2023 | 731.70 Mn |
| Sep 30, 2023 | 742.40 Mn |
| Jun 30, 2023 | 417.50 Mn |
| Mar 31, 2023 | 667.40 Mn |
| Dec 31, 2022 | 571.50 Mn |
| Sep 30, 2022 | 781.80 Mn |
| Jun 30, 2022 | 805.20 Mn |
| Mar 31, 2022 | 868.10 Mn |
| Dec 31, 2021 | 922.40 Mn |
| Sep 30, 2021 | 955.70 Mn |